NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 742860 | Null | 0.0228506033927957 | 0.50628799 |
NSC 745103 | D-Valine, N,N-dimethyl-, (1R,2E,6S,10E,11aS,13S,14aR)-4,6,7,8,9,11a,12,13,14,14a-decahydro-13-hydroxy-6-methyl-4-oxo-1H-cyclopent[f]oxacyclotridecin-1-yl ester, hydrochloride | 0.0228506033927957 | 0.0059841386 |
NSC 745343 | 1-Benzyl-3-hexadecyl-2-methylimidazolium chloride | 0.0228506033927957 | 0.42158982 |
NSC 748404 | Null | 0.0228506033927957 | 0.48600549 |
NSC 752464 | methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate | 0.0228506033927957 | 0.28574579 |
NSC 757113 | METHOTREXATE(+/-) | 0.0228506033927957 | 0.41317866 |
NSC 760181 | 9-(3-fluorobenzyl)-7-(3-fluorobenzyloxy)-2-(4-fluorobenzyl)-1-methyl-9H-beta-carbolinium bromide | 0.0228506033927957 | 0.40689201 |
NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0235234559682125 | 0.39378685 |
NSC 129757 | Null | 0.0235234559682125 | 0.086752369 |
NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0235234559682125 | 0.35742073 |